CCL3/MIP-1alpha is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D019496:Cancer Vaccines / Q000494:pharmacology*; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D045142:Cross-Priming; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis / Q000235:genetics*; D007376:Interleukin-2 / Q000096:biosynthesis / Q000235:genetics*; D007938:Leukemia / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D019402:Macrophage Inflammatory Proteins / Q000096:biosynthesis / Q000235:genetics*; D051379:Mice; D013997:Time Factors
D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D007376:Interleukin-2; D019402:Macrophage Inflammatory Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor